Black Diamond Therapeutics, Inc. (BDTX) financial statements and ratios from SEC XBRL: revenue $70.00M (TTM), net margin 32.0%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $70.00M |
| Net Margin | 32.0% |
| Price / Book | 1.32 |
| Altman Z-Score | -0.34 (distress) |
| Sector P/E (Healthcare) | 21.7 |
BDTX overview · BDTX earnings · BDTX KPIs · BDTX investor relations · BDTX ownership · BDTX peers · BDTX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.